NEW YORK — At OSN New York 2017, Robert J. Noecker, MD, MBA, gives an overview of the latest glaucoma therapies that work in the trabecular meshwork and are undergoing clinical trials. He said it is becoming more important to consider not only the pressure lowering of drops but also the method by which they lower IOP.
Month: November 2017
Company Profile for Iris Pharma
–(BUSINESS WIRE)–Iris Pharma is a world-leading Contract Research Organization (CRO) offering preclinical and clinical ophthalmology research services. Iris Pharma works hand-in-hand with customers and has helped bring more than 70 ocular drugs and m…
Ground-breaking eye health study offers new hope for AMD sufferers
Results from a two-year eye health study – the first of its kind in the world – have shown a new hope for people suffering from age-related macular degeneration (AMD), the most common cause of sight loss in the UK.
Gene Therapy Prevents Blindness
Here’s some exciting news about gene therapy and a potential cure for two types of inherited blindness. One injection may restore vision.
The post Gene Therapy Prevents Blindness appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseas…
Gene Therapy Prevents Blindness
Here’s some exciting news about gene therapy and a potential cure for two types of inherited blindness. One injection may restore vision.
The post Gene Therapy Prevents Blindness appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseas…
Gene Therapy Prevents Blindness
Here’s some exciting news about gene therapy and a potential cure for two types of inherited blindness. One injection may restore vision.
The post Gene Therapy Prevents Blindness appeared first on Retina Specialist | Fairfax, Virginia | Retinal Diseas…
Low Vision, Blindness Expected to Double in Next 30 Years
The incidence of low vision and blindness will double in the next 30 years among older adults in the United States, a study suggests. Medscape Medical News
VIDEO: OCTANe expanding beyond regional medtech organization
NEWPORT BEACH, Calif. — At the Medical Technology Innovation Forum, OCTANe President and CEO Bill Carpou discusses the organization’s growth and transformation from a regional Orange County nonprofit to a broader organization focused on connecting medical technology groups in Southern California.
FDA gives nod to Bausch + Lomb’s once-daily glaucoma drops
The FDA has approved the new drug application for the once-daily glaucoma treatment Vyzulta, according to a press release issued jointly by Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals, and Nicox S.A.Vyzulta (latanoprostene bunod ophthalmic s…
Cheap, Easy to Integrate Technology Converts Any 2D Ultrasound Machine into 3D Scanner
Portable ultrasound technology is improving and becoming more affordable, allowing it to be used in places previously impossible due to size and cost. Full size ultrasound imagers can do some impressive stuff, such as creating 3D reconstructions obtained from 2D probes. Now researchers at Duke University are introducing incredibly cheap and easy to integrate technology […]
White ring sign confirms plane of dissection during SMILE
Difficult lenticular extraction may sometimes occur in small incision lenticule extraction, especially if the posterior lenticular plane is inadvertently dissected before the anterior plane. Dr. Jacob has described the white ring sign as a means to fac…
What are the differences between pain management protocols for first and second eye cataract surgeries?
Click here to view the Cover Story to this Point/Counter.Ophthalmologists value surgical procedures and Snellen visual acuity while patients value quality of vision and the surgical experience. There is nothing that will ruin the patient impression of …
Young woman experiences painful decline in vision
A 25-year-old Caucasian woman with no ocular history was referred to Tufts New England Eye Center from an outside ophthalmologist for 5 days of pain, redness and progressive decline in vision in the right eye. She had a history of intravenous drug use …
Differentiation of Descemet’s detachments needed for proper management
Descemet’s membrane detachment is a complication occasionally faced by every ophthalmologist. It has been previously classified as planar, or less than a 1-mm gap between Descemet’s membrane and stroma, or nonplanar, or more than a 1-mm gap between Descemet’s membrane and stroma, based on morphology.
As head of the Cornea and Refractive Foundation at Dr. Agarwal’s Eye Hospital, I have had the opportunity to see, analyze and treat many cases of postoperative Descemet’s detachments that have been referred for not settling either spontaneously or after multiple air
How and when should ophthalmologists consider retirement?
“Do not go gentle into that good night, Old age should burn and rave at close of day; Rage, rage against the dying of the light.” – Dylan Thomas
“We should retire the word ‘retirement.’” – Herve Byron, MD
“Retirement at 65 is ridiculous. When I was 65 I still had pimples.” – George Burns
There are a bit more than 15,000 actively practicing ophthalmologists in America. Given the typical 35-or-so-year career span, this means that just more than eight of these eye surgeons retire every week.
One of these weeks, it will be your turn,
Round table: Diagnosis and treatment of concussion from the pediatric ophthalmologist’s point of view
Concussions are a topic of conversation inside and outside of medical communities.
Emphasis is being made on the long-term consequences of concussions, not only in professional sports but also in collegiate, high school and even under 11-year-old athletes. On the sidelines, non-physicians are tasked with “diagnosing” concussions; after the game, management falls to physicians.
At the American Association for Pediatric Ophthalmology and Strabismus meeting in Nashville, Tennessee, OSN Pediatrics/Strabismus Editorial Board Members expressed their frustrations with lack of information
Generation gaps can be meaningful for premium surgeons
Never did I realize as I started my private practice 25 years ago that I would be trying to sort out all the generation gaps and meeting the various refractive needs of all my patients, whether baby boomers, Generation X or Generation Y. Baby boomers account for at least 76 million Americans born between 1946 and 1964, and baby boomers control more than 80% of personal financial assets and more than 50% of all consumer spending. They buy 77% of all prescription drugs, 61% of over-the-counter drugs and 80% of all leisure travel. The term “Generation Jones” is typically used for
Consider patient perception of pain when planning cataract procedures
Cataract surgery is thought to be painless for most patients, but for the few who report discomfort during surgery, ophthalmologists can take precautions to limit pain.Most surgeons believe only 10% of patients report pain during cataract surgery; howe…
CMS alters guidelines for combined blepharoplasty and ptosis surgery
CMS has revised the July 2016 policy for same-day, same-eyelid blepharoplasty and ptosis surgery.The new policy, which went into effect Oct. 1, 2017, allows surgeons to bill patients for a cosmetic blepharoplasty surgery if it is performed on the same …
Attention to pain management critical for cataract surgery
It is important for all surgeons, including ophthalmic surgeons, to minimize the intraoperative and postoperative pain associated with the procedures they perform. Having undergone two hip replacements, arthroscopic surgery on both knees, a right total…